PT2356989T - Comprimido estável contendo derivado de 4,5-epoximorfinano - Google Patents
Comprimido estável contendo derivado de 4,5-epoximorfinanoInfo
- Publication number
- PT2356989T PT2356989T PT98220783T PT09822078T PT2356989T PT 2356989 T PT2356989 T PT 2356989T PT 98220783 T PT98220783 T PT 98220783T PT 09822078 T PT09822078 T PT 09822078T PT 2356989 T PT2356989 T PT 2356989T
- Authority
- PT
- Portugal
- Prior art keywords
- tablet containing
- stable tablet
- epoxymorphinan derivative
- epoxymorphinan
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008274579 | 2008-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2356989T true PT2356989T (pt) | 2018-03-09 |
Family
ID=42119418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98220783T PT2356989T (pt) | 2008-10-24 | 2009-10-23 | Comprimido estável contendo derivado de 4,5-epoximorfinano |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8829019B2 (pt) |
| EP (1) | EP2356989B1 (pt) |
| JP (2) | JP5648480B2 (pt) |
| KR (1) | KR101682963B1 (pt) |
| CN (1) | CN102196811B (pt) |
| AU (1) | AU2009307367B2 (pt) |
| BR (1) | BRPI0920599B1 (pt) |
| CA (1) | CA2740476C (pt) |
| DK (1) | DK2356989T3 (pt) |
| ES (1) | ES2660001T3 (pt) |
| HU (1) | HUE036876T2 (pt) |
| MX (1) | MX2011004307A (pt) |
| PL (1) | PL2356989T3 (pt) |
| PT (1) | PT2356989T (pt) |
| TR (1) | TR201802379T4 (pt) |
| WO (1) | WO2010047381A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013009505B1 (pt) * | 2010-10-19 | 2022-06-21 | Memorial Sloan-Kettering Cancer Center | Composto, composição farmacêutica, métodos para ensaio quanto a um receptor, e, usos de um composto |
| JP5818219B2 (ja) * | 2012-05-14 | 2015-11-18 | 塩野義製薬株式会社 | ６，７−不飽和−７−カルバモイルモルヒナン誘導体含有製剤 |
| TWI449704B (zh) * | 2013-04-26 | 2014-08-21 | Everlight Chem Ind Corp | 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物 |
| CA3241654A1 (en) | 2015-04-30 | 2016-11-03 | Memorial Sloan-Kettering Cancer Center | Mitragynine analogs and uses thereof |
| JP6858575B2 (ja) * | 2016-01-29 | 2021-04-14 | 沢井製薬株式会社 | ナルフラフィン含有口腔内崩壊錠 |
| BR112018075619A2 (pt) | 2016-07-29 | 2019-04-09 | Toray Industries, Inc. | preparação sólida. |
| US11071734B2 (en) * | 2017-03-31 | 2021-07-27 | Toray Industries, Inc. | Tableted medicinal composition comprising nalfurafine |
| CA3091752A1 (en) | 2018-03-08 | 2019-09-12 | Victoria Link Ltd | Treatment of demyelinating diseases |
| US11214577B2 (en) | 2019-03-29 | 2022-01-04 | Humanwell Pharmaceutical US | Morphinans useful for treating medical disorders |
| CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2597475A (en) * | 1949-03-09 | 1952-05-20 | Gilbert & Barker Mfg Co | Separator for removing water from gasoline |
| GB8820327D0 (en) | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
| NZ246687A (en) | 1992-01-23 | 1996-12-20 | Toray Industries | Morphinan derivative and pharmaceutical compositions thereof |
| US20010014340A1 (en) | 1996-06-14 | 2001-08-16 | Motohiro Ohta | Intrabuccally rapidly disintegrating tablet |
| DE59800046D1 (de) | 1997-02-14 | 1999-12-23 | Goedecke Ag | Stabilisierung von naloxonhydrochlorid |
| KR20000016052A (ko) * | 1997-03-27 | 2000-03-25 | 히라이 가쯔히꼬 | 몰피난 유도체 및 의약용도_ |
| CN100379419C (zh) * | 1997-07-11 | 2008-04-09 | 东丽株式会社 | 含有4,5-环氧吗啡喃衍生物的稳定的药物组合物 |
| US6572891B1 (en) | 1999-10-23 | 2003-06-03 | Alkaloid Ad | Sublingual oral dosage form |
| JP3595765B2 (ja) * | 2000-09-27 | 2004-12-02 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 |
| JP4755353B2 (ja) | 2001-04-02 | 2011-08-24 | 興和株式会社 | ビタミンｂ１製剤 |
| ATE510534T1 (de) | 2002-03-14 | 2011-06-15 | Euro Celtique Sa | Naltrexonhydrochlorid-zusammensetzungen |
| AU2003272944B2 (en) * | 2002-10-09 | 2009-11-12 | Toray Industries, Inc. | Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| EP2368554B1 (en) | 2003-04-08 | 2014-12-24 | Progenics Pharmaceuticals, Inc. | Pharmaceutical formulations containing methylnaltrexone |
| TW200507882A (en) | 2003-07-17 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Solid formulations |
| EP1813274B1 (en) | 2004-10-06 | 2009-12-16 | Eisai R&D Management Co., Ltd. | Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
| JP4567640B2 (ja) | 2005-07-29 | 2010-10-20 | 田辺三菱製薬株式会社 | 小型化塩酸サルポグレラート経口投与製剤 |
| KR20080065664A (ko) * | 2005-11-09 | 2008-07-14 | 도레이 가부시끼가이샤 | 기능성 장장해의 치료 또는 예방제 |
| US8652529B2 (en) * | 2005-11-10 | 2014-02-18 | Flamel Technologies | Anti-misuse microparticulate oral pharmaceutical form |
| JP5204976B2 (ja) * | 2006-01-27 | 2013-06-05 | 富山化学工業株式会社 | イグラチモドを含有する速崩壊性錠剤 |
| US20070196494A1 (en) * | 2006-02-17 | 2007-08-23 | Arnaud Grenier | Low-friability, patient-friendly orally disintegrating formulations |
| WO2008015220A1 (en) * | 2006-08-04 | 2008-02-07 | Ethypharm | Granule and orally disintegrating tablet comprising oxycodone |
| JP5895535B2 (ja) * | 2010-08-26 | 2016-03-30 | 東レ株式会社 | 免疫原性組成物 |
-
2009
- 2009-10-23 CA CA2740476A patent/CA2740476C/en active Active
- 2009-10-23 PL PL09822078T patent/PL2356989T3/pl unknown
- 2009-10-23 BR BRPI0920599-3A patent/BRPI0920599B1/pt active IP Right Grant
- 2009-10-23 TR TR2018/02379T patent/TR201802379T4/tr unknown
- 2009-10-23 HU HUE09822078A patent/HUE036876T2/hu unknown
- 2009-10-23 WO PCT/JP2009/068228 patent/WO2010047381A1/ja active Application Filing
- 2009-10-23 MX MX2011004307A patent/MX2011004307A/es unknown
- 2009-10-23 KR KR1020117011543A patent/KR101682963B1/ko active IP Right Grant
- 2009-10-23 ES ES09822078.3T patent/ES2660001T3/es active Active
- 2009-10-23 US US13/125,726 patent/US8829019B2/en active Active
- 2009-10-23 EP EP09822078.3A patent/EP2356989B1/en active Active
- 2009-10-23 JP JP2010534846A patent/JP5648480B2/ja active Active
- 2009-10-23 AU AU2009307367A patent/AU2009307367B2/en active Active
- 2009-10-23 DK DK09822078.3T patent/DK2356989T3/en active
- 2009-10-23 PT PT98220783T patent/PT2356989T/pt unknown
- 2009-10-23 CN CN200980142056.8A patent/CN102196811B/zh active Active
-
2014
- 2014-03-07 JP JP2014045214A patent/JP5971272B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2356989A4 (en) | 2013-05-08 |
| CA2740476A1 (en) | 2010-04-29 |
| EP2356989A1 (en) | 2011-08-17 |
| KR101682963B1 (ko) | 2016-12-06 |
| HUE036876T2 (hu) | 2018-08-28 |
| WO2010047381A1 (ja) | 2010-04-29 |
| BRPI0920599A2 (pt) | 2020-12-15 |
| DK2356989T3 (en) | 2018-05-07 |
| CA2740476C (en) | 2016-04-05 |
| CN102196811B (zh) | 2014-03-19 |
| JP5971272B2 (ja) | 2016-08-17 |
| US8829019B2 (en) | 2014-09-09 |
| BRPI0920599B1 (pt) | 2021-10-19 |
| US20120114752A1 (en) | 2012-05-10 |
| CN102196811A (zh) | 2011-09-21 |
| MX2011004307A (es) | 2011-07-28 |
| JP5648480B2 (ja) | 2015-01-07 |
| ES2660001T3 (es) | 2018-03-20 |
| AU2009307367A1 (en) | 2010-04-29 |
| AU2009307367B2 (en) | 2015-04-23 |
| TR201802379T4 (tr) | 2018-03-21 |
| EP2356989B1 (en) | 2018-02-07 |
| PL2356989T3 (pl) | 2018-07-31 |
| JPWO2010047381A1 (ja) | 2012-03-22 |
| KR20110074613A (ko) | 2011-06-30 |
| JP2014141503A (ja) | 2014-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
| IL201973A0 (en) | 3,3-spiroindolinone derivatives | |
| EP2356989A4 (en) | STABLE TABLET WITH 4,5-EPOXYMORPHINAN DERIVATIVE | |
| ZA201001797B (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| EP2361902A4 (en) | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG | |
| HRP20130728T1 (en) | 7-piperidinoalkyl-3,4-dihydroquinolone derivative | |
| IL225694A0 (en) | Compounds 6,5- dihydro-h1-pyridine-2-one | |
| SI2356123T1 (sl) | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni | |
| ZA201008657B (en) | 4,5-dihydro-oxazol-2-yl derivatives | |
| AP2010005345A0 (en) | Indazole derivatives. | |
| SI2513119T1 (sl) | 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati | |
| HU0800591D0 (en) | Stable pharmaceutical combination | |
| EP2202231A4 (en) | 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE | |
| ZA201103374B (en) | Shelf stable capsules | |
| IL201444A0 (en) | New 4, 8 - diphenyl - polyazanaphthalene derivatives | |
| ZA201005346B (en) | 3,8-diaminotetrahydroquinoline derivative | |
| HK1162032A1 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2- | |
| HK1161684A1 (en) | 5,6-dihydro-1h-pyridin-2-one compounds 56- -1h--2- | |
| HK1151801A1 (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid | |
| HK1182939A1 (en) | Stable pharmaceutical composition | |
| IL219623A0 (en) | [1,5]-diazocin derivatives | |
| GB0813815D0 (en) | Corcost Pre 1001,10 | |
| GB0808811D0 (en) | Algabe 2.1 | |
| GB0816954D0 (en) | Tablet holder |